BB's Stock Haven

[Gatorelf]

CBLI smoken again, Fears of spreading radiation in Japan's crisis has put CBLI on radar. Cleveland Biolabs has been developing a drug candidate to protect humans from acute stresses such as radiation, chemotherapy or nuclear bomb exposure with the help of the U.S. Department of Defense, the Armed Forces Radiobiology Research Institute and others. The company is currently getting $15.6 million over three years from Project BioShield, a US government anti-terror program. Cleveland Biolabs, Inc. engages in the discovery, development, and commercialization of products for cancer treatment and protection of normal tissues from radiation and other acute stresses.